The long-term effects of chemotherapy on normal blood cells

化疗对正常血细胞的长期影响

阅读:13
作者:Emily Mitchell # ,My H Pham # ,Anna Clay # ,Rashesh Sanghvi ,Nicholas Williams ,Sandra Pietsch ,Joanne I Hsu ,Nina Friesgaard Øbro ,Hyunchul Jung ,Aditi Vedi ,Sarah Moody ,Jingwei Wang ,Daniel Leonganmornlert ,Michael Spencer Chapman ,Ellie Dunstone ,Anna Santarsieri ,Alex Cagan ,Heather E Machado ,E Joanna Baxter ,George Follows ,Daniel J Hodson ,Ultan McDermott ,Gary J Doherty ,Inigo Martincorena ,Laura Humphreys ,Krishnaa Mahbubani ,Kourosh Saeb Parsy ,Koichi Takahashi ,Margaret A Goodell ,David Kent ,Elisa Laurenti ,Peter J Campbell ,Raheleh Rahbari ,Jyoti Nangalia # ,Michael R Stratton #

Abstract

Several chemotherapeutic agents act by increasing DNA damage in cancer cells, triggering cell death. However, there is limited understanding of the extent and long-term consequences of collateral DNA damage in normal tissues. To investigate the impact of chemotherapy on mutation burdens and the cell population structure of normal tissue, we sequenced blood cell genomes from 23 individuals aged 3-80 years who were treated with a range of chemotherapy regimens. Substantial additional somatic mutation loads with characteristic mutational signatures were imposed by some chemotherapeutic agents, but the effects were dependent on the drug and blood cell types. Chemotherapy induced premature changes in the cell population structure of normal blood, similar to those caused by normal aging. The results show the long-term biological consequences of cytotoxic agents to which a substantial fraction of the population is exposed as part of disease management, raising mechanistic questions and highlighting opportunities for the mitigation of adverse effects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。